Polypharmacy and relapse of schizophrenia: are they related?
Introduction Polypharmacy can be the cause of deliberate discontinuation of medication and consequent relapse of schizophrenia. Objectives To establish the one-year rate of relapse in the patients with schizophrenia with regard to monotherapy or polypharmacy. Methods The sample of all hospitalize...
| Main Authors: | R. Softic, S. Osmanovic, N. Becarevic |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2022-06-01
|
| Series: | European Psychiatry |
| Subjects: | |
| Online Access: | https://www.cambridge.org/core/product/identifier/S0924933822019757/type/journal_article |
Similar Items
-
Polypharmacy Management of Antipsychotics in Patients with Schizophrenia
by: Hiroyuki Kamei
Published: (2022-11-01) -
Antipsychotic prescription and polypharmacy among outpatients with schizophrenia in a Nigerian hospital
by: Ihechiluru Goodnews Anozie, et al.
Published: (2020-01-01) -
Determination of Changes in Blood Biomarker Levels in Antipsychotic Polypharmacy and Aripiprazole Monotherapy in Patients With Long-term Schizophrenia
by: Venus Vatankhah, et al.
Published: (2019-12-01) -
Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
by: Norio Yasui‐Furukori, et al.
Published: (2020-09-01) -
Factors influencing relapse in patients with schizophrenia
by: P Nabeel, et al.
Published: (2023-01-01)